The impact of epilepsy from the patient's perspective II: Views about therapy and health care

Epilepsy Research

Volumn 41, Issue 1, 2000, Pages 53-62

  Fisher, Robert S ^a   Vickrey, Barbara G ^b   Gibson, Patricia ^c   Hermann, Bruce ^d   Penovich, Patricia ^e   Scherer, Ann ^f   Walker, Steven ^g  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e MINNESOTA EPILEPSY GROUP   (United States)

^f Epilepsy Foundation of America   (United States)

^g SANOFI   (France)

Author keywords

Anti epileptic medications; Epilepsy; Evaluation of medical care; Seizures; Surveys

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ACADEMIC ACHIEVEMENT; ANTICONVULSANT THERAPY; ARTICLE; COGNITIVE DEFECT; DISEASE CONTROL; DRUG INDUCED DISEASE; EPILEPSY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PREGNANCY; PRIORITY JOURNAL; SEIZURE; SEXUAL DYSFUNCTION;

EID: 0033898798     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00128-5     Document Type: Article

References (24)

1. Anonymous, Nov 5 1997. Growth of managed care. Epilepsy. Growth of managed care. Epilepsy USA.
2. Averis A. Complementary therapies and epilepsy: a nursing perspective. Aust. J. Holistic. Nurs. 2:1995;26-32.
3. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia. 38:1997;353-362.
4. Ben-Menachem E., Mañon-Espaillat R., Ristanovic R. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia. 35:1994;616-626.
5. Chaplin J.E., Yepez R., Shorvon S., Floyd M. A quantitative approach to measuring the social effects of epilepsy. Neuroepidemiology. 9:1990;151-158.
6. Chaplin J.E., Lasso R.Y., Shorvon S.D., Floyd M. National general practice study of epilepsy: the social and psychological effects of a recent diagnosis of epilepsy. Br. Med. J. 304:1992;1416-1418.
7. Chappell B. Epilepsy: patient views on their condition and treatment. Seizure. 1:1992;103-109.
8. Cramer J.A. Quality of life assessment in clinical practice. Neurology. 53:1999a;S49-S52.
9. Cramer J.A., Fisher R., Ben-Menachem E., French J., Mattson R.H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia. 40:1999b;590-600.
10. Dansky L.V., Andermann E., Andermann F. Marriage and fertility in epileptic patients. Epilepsia. 21:1980;261-271.
11. Dilorio C., Manteuffel B. Preferences concerning epilepsy education: opinions of nurses, physicians, and persons with epilepsy. J. Neurosci. Nurs. 27:1995;29-34.
12. Elwes R.D., Marshall J., Beattie A., Newman P.K. Epilepsy and employment: a community based survey in an area of high unemployment. J. Neurol. Neurosurg. Psych. 54:1991;200-203.
13. Engel J.J. Surgical Treatment of the Epilepsies. 1993;Raven Press, New York.
14. Fisher R.S. Newer antiepileptic drugs. Wyllie E. The Treatment of Epilepsy: Principles and Practice. 1996;Lea & Febiger, Malvern, Pennsylvania.
15. Fisher R.S., Handforth A. Reassessment: vagus nerve stimulation for epilepsy: a report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 53:1999;666-669.
16. Gordon K., MacSween J., Dooley J., Camfield C., Camfield P., Smith B. Families are content to discontinue antiepileptic drugs at different risks than their physicians. Epilepsia. 37:1996;557-562.
17. Hart Y.M., Shorvon S.D. The nature of epilepsy in the general population. II: medical care. Epilepsy Res. 21:1995;51-58.
18. Henriksen O. Education and epilepsy: assessment and remediation. Epilepsia. 31(suppl 4):1990;S21-S25.
19. Ieiri I., Hirata K., Higuchi S. et al. Pharmacoepidemiological study on adverse reactions of antiepileptic drugs. Chem. Pharm. Bull. 40:1992;1280-1288.
20. Krumholz A., Fisher R.S., Lesser R.P., Hauser W.A. Driving and epilepsy: a review and reappraisal. J. Am. Med. Ass. 265:1991;622-626.
21. Livingston S., Berman W. Participation of epileptic patients in sports. J. Am. Med. Ass. 224:1973;236-238.
22. Mattson R.H., Cramer J.A., Collins J.F. et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. New Engl. J. Med. 313:1985;145-151.
23. Roper Poll, 1993, Survey of people with epilepsy. Presented at the American Academy of Neurology.
24. Shorvon S.D., Reynolds E.H. Reduction in polypharmacy for epilepsy. Br. Med. J. 2:1979;1023-1025.